Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESTIS: Early Stop of Targeted Treatment in Children with Systemic JIA
2024-518684-35-00Phase 4Authorised
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anakinra in systemic juvenile idiopathic arthritis (SJIA), sponsored by University Medical Center Utrecht. Planned start Dec 2024; status: authorised.
02
Drugs
anakinra
03
Conditions
systemic juvenile idiopathic arthritis (SJIA)
Beyond the preview
Go deeper on 2024-518684-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518684-35-00.